3439.60
4.17%
HDFC Securities
Revenue grew by 10.76% to Rs. 763.43 Cr in Q4FY17 when compared to the previous quarter.
GlaxoSmithKline Pharmaceuticals Ltd. is trading above all available SMAs
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended